Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase III Multicentre, Parallel-group, Randomized, Placebo-controlled, Double-blind Clinical Trial to Study the Efficacy and Safety of MK-4117 in Japanese Subjects With Chronic Urticaria.

NCT01916967 is registered in ClinicalTrials.gov with Organon and Co as lead sponsor.

NCT NCT01916967
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01916967 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase III Multicentre, Parallel-group, Randomized, Placebo-controlled, Double-blind Clinical Trial to Study the Efficacy and Safety of MK-4117 in Japanese Subjects With Chronic Urticaria.
Lead sponsor
Organon and Co
Phase
Phase 3
Overall status
Completed
Start date
August 27, 2013
Completion date
March 13, 2014
Enrollment
239 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

urticaria